MEGIN OY

Their core work

MEGIN OY (operating as Elekta Neuromag) is a Finnish manufacturer of magnetoencephalography (MEG) systems — precision instruments that detect the extremely faint magnetic fields generated by neural activity in the brain. Their MEG devices are used in clinical neuroscience and research hospitals worldwide for mapping brain function non-invasively. Within H2020 projects, they contribute their expertise in ultra-sensitive magnetic field detection, both for advancing brain imaging in clinical applications and for exploring next-generation quantum sensing technologies based on atomic magnetometers.

What they specialise in

How they've shifted over time

MEGIN's early H2020 involvement (2015–2017) centered squarely on clinical brain imaging — improving MEG-based neuroimaging for children's brain disorders and tackling mathematical challenges of electromagnetic source localization. Their later participation (2018 onward) shifted toward quantum sensing hardware, with macQsimal exploring miniature atomic vapor cells, MEMS-based atomic clocks, gyroscopes, and magnetometers. This progression suggests the company is building on its decades of experience in sensitive magnetic measurement to position itself in the broader quantum technology sensor market.

MEGIN is expanding from its established MEG niche into miniaturized quantum sensors, signaling interest in applications well beyond neuroscience — including navigation, metrology, and industrial sensing.

How they like to work

MEGIN operates exclusively as a specialist participant, never leading consortia. With 32 unique partners across 12 countries from just 3 projects, they join relatively large, research-intensive consortia where they contribute specific instrumentation and measurement expertise. This pattern is typical of a technology provider that brings essential hardware capabilities to academic-led research teams rather than driving the research agenda itself.

Despite only 3 projects, MEGIN has built connections with 32 distinct partners across 12 countries, reflecting their participation in broad European research consortia spanning neuroscience and quantum technology communities.

What sets them apart

MEGIN is one of very few companies in the world that manufactures commercial MEG systems, giving them a near-unique position at the intersection of precision magnetic sensing and clinical neuroscience. Their move into quantum sensing (atomic magnetometers, vapor cells) connects their deep know-how in detecting extremely weak magnetic fields to an entirely new generation of compact sensor technologies. For consortium builders, they offer something rare: a private company that actually manufactures the instruments, not just researches them.

Highlights from their portfolio

• BREAKBEN
  Largest funding (EUR 413,735) and directly targets improving the core technology behind MEGIN's commercial products — electromagnetic brain imaging accuracy.
• macQsimal
  Represents a strategic pivot into quantum sensing and MEMS-based atomic devices, extending MEGIN's magnetic measurement expertise beyond neuroscience into metrology and industrial applications.